A panelist discusses the evolving role of prophylactic tocilizumab in reducing cytokine release syndrome during bispecific antibody therapy, enabling outpatient treatment and improving patient ...
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...
Okay, we’re done. We’re well and truly done with 2021. Amy Lindgren If you like how that sounds, then you’ll love this: 2022 can be the year for you. (Feel free to add a little dance step here.) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback